tumortargeted

Nanotechnology

Polymer cloak stabilizes cytokine complexes to generate tumor-targeted nanosuperagonists

Mechanism of action of nanosuperagonists. Credit: Horacio Cabral A group led by Professor Horacio Cabral has discovered a new way to build therapeutics based on protein complexes. Professor Cabral is a visiting researcher at the Innovation Center for Nanomedicine (iCONM) and an associate professor at the Department of Biotechnology, Graduate School of Engineering, University of Tokyo. The paper, titled “Nano-enabled…